Filing Details
- Accession Number:
- 0001231977-11-000083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-30 17:37:21
- Reporting Period:
- 2011-11-28
- Filing Date:
- 2011-11-30
- Accepted Time:
- 2011-11-30 17:37:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1457477 | David Hallal | C/O Alexion Pharmaceuticals, Inc 352 Knotter Drive Cheshire CT 06410 | Svp, Global Commercial Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Acquisiton | 2011-11-28 | 20,000 | $11.92 | 59,735 | No | 4 | M | Direct | |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2011-11-28 | 20,000 | $66.59 | 39,735 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Option to Purchase Common Stock | Disposition | 2011-11-28 | 20,000 | $0.00 | 20,000 | $11.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 54,308 | 2007-10-11 | 2017-07-11 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $66.44 - $66.80. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the amount of shares sold at each price.
Billionaire Hedge Funds
